ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2018

Apr 24, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2018-03-02

Reporting Person: Velden Claus Vander (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$2.60	2028-03-02	Common Stock (50000)		Direct

Footnotes

F1: Dr. van der Velden holds options to purchase fifty thousand (50,000) shares of common stock of the Corporation at an option price per share of $2.60, said options to vest in annual equal installments over a three year period commencing on March 2, 2018, exercisable as follows: 16,667 shares on March 2, 2019, 16,667 shares on March 2, 2020 and 16,666 shares on March 2, 2021.